Australia markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.03500.0000 (0.00%)
At close: 01:12PM AEDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
-
-
-
-
663.405
Gross profit
-
-
-
-
663.405
Operating expenses
Research development
747.181
747.181
840.815
1,289
776.256
Selling general and administrative
1,376
1,376
1,620
1,991
2,437
Total operating expenses
3,022
3,022
3,113
4,206
4,482
Operating income or loss
-3,022
-3,022
-3,113
-4,206
-3,819
Interest expense
3.32
3.32
0.3
-
-
Total other income/expenses net
487.235
487.235
1,108
789.211
807.966
Income before tax
-2,532
-2,532
-1,996
-3,365
-2,868
Income tax expense
0
0
0
0
0
Income from continuing operations
-2,532
-2,532
-1,996
-3,365
-2,868
Net income
-2,532
-2,532
-1,996
-3,365
-2,868
Net income available to common shareholders
-2,532
-2,532
-1,996
-3,365
-2,868
Basic EPS
-
-
-0.03
-0.07
-0.06
Diluted EPS
-
-
-0.03
-0.07
-0.06
Basic average shares
-
-
64,731
51,273
51,007
Diluted average shares
-
-
64,731
51,273
51,007
EBITDA
-
-2,504
-1,989
-4,190
-3,796